Searching for a better mousetrap for ablation of Barrett’s esophagus

Endoscopy 2022; 54(06): 553-554
DOI: 10.1055/a-1722-2885

Editorial

Referring to Gotink AW et al. p. 545–552

John A. Dumot

University Hospitals Cleveland Medical Center, Digestive Health Institute, Cleveland, Ohio, United States

References
1 Gotink AW, Peters Y, Bruno MJ. et al. Nonthermal resection device for ablation of Barrett’s esophagus: a feasibility and safety study. Endoscopy 2022; 54: 545-552
2 Brown A, Kraft D, Schmitz SM. et al. Association of industry sponsorship to published outcomes in gastrointestinal clinical research. Clin Gastroenterol Hepatol 2006; 4: 1445-1451
3 Shaheen NJ, Falk GW, Iyer PG. et al. ACG Clinical Guideline: Diagnosis and management of Barrett’s esophagus. Am J Gastroenterol 2016; 111: 30-50
4 Tariq R, Enslin S, Hayat M. et al. Efficacy of cryotherapy as a primary endoscopic ablation modality for dysplastic Barrett’s esophagus and early esophageal neoplasia: a systemic review and meta-analysis. Cancer Control 2020;
5 Visrodia K, Zakko L, Singh S. et al. Cryotherapy for persistent Barrett’s esophagus after radiofrequency ablation: a systematic review and meta-analysis. Gastrointest Endosc 2018; 87: 1396-1404